Jacob L Bouchard - JoVE Visualize

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

Molecules (Basel, Switzerland)|June 19, 2019

Aβ(M1-40) and Wild-Type Aβ40 Self-Assemble into Oligomers with Distinct Quaternary StructuresJacob L Bouchard, Taylor C Davey, Todd M Doran

Chemical Communications (Cambridge, England)|December 22, 2021

Photocaged dicarbonyl probe provides spatiotemporal control over protein glycationAlexander K Hurben, Peng Ge, Jacob L Bouchard, et al.

Bioconjugate Chemistry|January 12, 2022

Chemoselective Bioconjugation of Amyloidogenic Protein Antigens to PEGylated Microspheres Enables Detection of α-Synuclein Autoantibodies in Human PlasmaPeng Ge, Mu Yang, Jacob L Bouchard, et al.

ACS Pharmacology & Translational Science|April 18, 2024

Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)]Mark D Ericson, Katie T Freeman, Courtney M Larson, et al.

ACS Chemical Neuroscience|October 15, 2024

Classics in Chemical Neuroscience: MedetomidinePedro de Andrade Horn, Tomayo I Berida, Lauren C Parr, et al.

Journal of Medicinal Chemistry|June 12, 2023

Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH<sub>2</sub>] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH<sub>2</sub>]Mark D Ericson, Linh T Tran, Sarah S Mathre, et al.

Journal of Natural Products|April 1, 2025

Total Synthesis and Pharmacological Evaluation of Phochrodines A-CJacob L Bouchard, Sichen Chang, Srinivasan Krishnan, et al.

Assay and Drug Development Technologies|February 17, 2026

Identification of Kir2.1 Inhibitors from a High-Throughput ScreenJacob L Bouchard, Pedro de Andrade Horn, Yu Nishio, et al.

ACS Pharmacology & Translational Science|April 18, 2024

Discovery of Protease-Activated Receptor 4 (PAR4)-Tethered Ligand Antagonists Using Ultralarge Virtual ScreeningShannon T Smith, Jackson B Cassada, Lukas Von Bredow, et al.

Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

Molecules (Basel, Switzerland)|June 19, 2019

Aβ(M1-40) and Wild-Type Aβ40 Self-Assemble into Oligomers with Distinct Quaternary StructuresJacob L Bouchard, Taylor C Davey, Todd M Doran

Chemical Communications (Cambridge, England)|December 22, 2021

Photocaged dicarbonyl probe provides spatiotemporal control over protein glycationAlexander K Hurben, Peng Ge, Jacob L Bouchard, et al.

Bioconjugate Chemistry|January 12, 2022

Chemoselective Bioconjugation of Amyloidogenic Protein Antigens to PEGylated Microspheres Enables Detection of α-Synuclein Autoantibodies in Human PlasmaPeng Ge, Mu Yang, Jacob L Bouchard, et al.

ACS Pharmacology & Translational Science|April 18, 2024

Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)]Mark D Ericson, Katie T Freeman, Courtney M Larson, et al.

ACS Chemical Neuroscience|October 15, 2024

Classics in Chemical Neuroscience: MedetomidinePedro de Andrade Horn, Tomayo I Berida, Lauren C Parr, et al.

Journal of Medicinal Chemistry|June 12, 2023

Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH<sub>2</sub>] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH<sub>2</sub>]Mark D Ericson, Linh T Tran, Sarah S Mathre, et al.

Journal of Natural Products|April 1, 2025

Total Synthesis and Pharmacological Evaluation of Phochrodines A-CJacob L Bouchard, Sichen Chang, Srinivasan Krishnan, et al.

Assay and Drug Development Technologies|February 17, 2026

Identification of Kir2.1 Inhibitors from a High-Throughput ScreenJacob L Bouchard, Pedro de Andrade Horn, Yu Nishio, et al.

ACS Pharmacology & Translational Science|April 18, 2024

Discovery of Protease-Activated Receptor 4 (PAR4)-Tethered Ligand Antagonists Using Ultralarge Virtual ScreeningShannon T Smith, Jackson B Cassada, Lukas Von Bredow, et al.

Pageof 1